Reply to: "Comments on the paper 'Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple-negative breast cancer' by Y. Chen et al."

Int J Cancer. 2025 Aug 1;157(3):590-591. doi: 10.1002/ijc.35434. Epub 2025 Apr 18.

Youdinghuan Chen^{1

2

3}, Lucas A Salas^{1

2}, Jonathan D Marotti⁴, Nicole P Jenkins^{1

3}, Chao Cheng^{1

5}, Todd W Miller^{1

6}, Arminja N Kettenbach^{1

3}, Brock C Christensen^{1

2

7}

¹ Department of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
² Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
³ Department of Biochemistry and Cell Biology, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
⁴ Department of Pathology and Laboratory Medicine, Dartmouth Medical Center, Lebanon, New Hampshire, USA.
⁵ Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
⁶ Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
⁷ Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.

No abstract available

Publication types